Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Transthera Sciences (nanjing), Inc.

Clinical trials sponsored by Transthera Sciences (nanjing), Inc., explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New pill targets bile duct cancer that resists standard treatments

Disease control Ongoing

This Phase 3 trial tests an oral drug called tinengotinib against standard treatments chosen by the doctor for people with advanced bile duct cancer (cholangiocarcinoma) that has a specific genetic alteration (FGFR) and has stopped responding to chemotherapy and an FGFR inhibitor…

Phase: PHASE3 • Sponsor: TransThera Sciences (Nanjing), Inc. • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC